Researchers have made a breakthrough in brain cancer treatment by identifying a key process that can be targeted with a new drug, AZD8055, which combines with Temozolomide to extend animal life by 30%. This discovery is leading to the start of a human phase I/II clinical trial as early as Spring 2015.
A new research study published in JAMA Pediatrics analyzed the effects of different exercise programs on obese youths. The study found that combining aerobic exercise with resistance training resulted in significant weight loss and reduced body fat compared to other exercise programs or diet-only control groups.
A team of researchers at the University of Calgary has discovered a new mechanism that can reverse chronic pain conditions. They found that interfering with the communication between a specific enzyme and calcium channels in nerve cells can shut off pain signals.